ArticleJournal of clinical medicine2026

Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.

Maral Martin Mildanoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.